drugset / Trial / NCT04265105

Fluticasone-Vilanterol Once Daily Dose for the Treatment of Mild Asthma in Adults

NCT04265105 ↗

RandomizedParallel-groupOpen-labelTreatment

Summary

Investigators will test the superiority of Superiority Trial of Fluticasone-Vilanterol as needed in mild asthma compared to standard of care

Timeline

Start
2021-12-22
Primary completion
2023-01-18
Completion
2023-01-18

Drugs

EvaluationDrugModalityDoseRoute
Subject fluticasone-vilanterol Unknown — Inhaled

Indications